Details for New Drug Application (NDA): 020256

✉ Email this page to a colleague

NDA 020256 describes NEUROLITE, which is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. Additional details are available on the NEUROLITE profile page.

The generic ingredient in NEUROLITE is technetium tc-99m bicisate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m bicisate kit profile page.

Summary for 020256

Tradename:	NEUROLITE
Applicant:	Lantheus Medcl
Ingredient:	technetium tc-99m bicisate kit
Patents:	0

Suppliers and Packaging for NDA: 020256

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NEUROLITE	technetium tc-99m bicisate kit	INJECTABLE;INJECTION	020256	NDA	Lantheus Medical Imaging, Inc.	11994-006	11994-006-02	2 KIT in 1 PACKAGE, COMBINATION (11994-006-02) / 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (11994-002-01) * 1 mL in 1 VIAL (11994-004-01)
NEUROLITE	technetium tc-99m bicisate kit	INJECTABLE;INJECTION	020256	NDA	Lantheus Medical Imaging, Inc.	11994-006	11994-006-05	5 KIT in 1 PACKAGE, COMBINATION (11994-006-05) / 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (11994-002-01) * 1 mL in 1 VIAL (11994-004-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	N/A
Approval Date:	Nov 23, 1994	TE:		RLD:	Yes

Expired US Patents for NDA 020256

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lantheus Medcl	NEUROLITE	technetium tc-99m bicisate kit	INJECTABLE;INJECTION	020256-001	Nov 23, 1994	5,279,811	⤷ Subscribe
Lantheus Medcl	NEUROLITE	technetium tc-99m bicisate kit	INJECTABLE;INJECTION	020256-001	Nov 23, 1994	5,431,900	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.